Special Issue "Peptide-Based Drug Development"
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: 30 April 2021.
Interests: peptide science; chemical biology; conformational restriction; amino acid; polyamide and heterocycle synthesis; medicinal chemistry; diversity-oriented synthesis; peptidomimetic; drug discovery
Interests: peptide inhibitor design; ligand binding; structural biology; protein-RNA interactions
Interests: biomolecular NMR spectroscopy; peptide and protein structure; peptide drug design; cyclic peptide; peptide chemistry; neuropeptide
Peptides and their analogs are readily accessible by chemical and biological methods. With ideal properties for forming high affinity and specific interactions with target protein surfaces, they have established an important niche in the drug development spectrum complementing small molecule and biological therapeutics. Among the most successful biomedicines in use today, peptide-based drugs show great promise for the future. The theme issue “Peptide-Based Drug Development” invites contributions across the spectrum of advances, including novel bioactive peptides, library-based peptide lead discovery, and chemistry for improving peptide pharmacokinetic (ADMET) properties.
Prof. Dr. William D. Lubell
Assoc. Prof. Jackie Wilce
Dr. Johan Rosengren
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.